Articles & Announcements

Digital disrupters take big pharma ‘beyond the pill’

Financial Times features Livongo.

Digital disrupters take big pharma ‘beyond the pill’

Start-ups are developing gadgets that are reducing the need for medication

by: in London

After Maggie Philyaw developed Type 2 diabetes, she found solace not in the medicines of the pharmaceutical industry, but the technology of Silicon Valley. Two years ago, her then employer in North Carolina signed Ms Philyaw up to a programme run by Livongo Health, a California-based start-up, which gave her a device, smaller than an iPhone and fitted with a cellular chip, that keeps track of her blood sugar levels.

Full article here >>

Digital Diabetes Solutions Can Play Valuable Role in Workplace Diabetes Interventions, Says Northeast Business Group on Health Report

The Northeast Business Group on Health released “Digital Diabetes Solutions in Action: An Opportunity Study.” The report profiles implementation of the Livongo for Diabetes program at Mount Sinai Health System and Iron Mountain.

“Diabetes shows no signs of abating as a key concern for our employer members, despite investments in a wide range of targeted diabetes prevention and management strategies over the years, including biometric screenings, nutrition and exercise counseling, onsite clinics and incentives for diabetes medication adherence,” said Laurel Pickering, President and CEO of NEBGH. “So the question is whether investing in digital health solutions is a worthwhile addition to these strategies. Based on the Mt. Sinai pilot program as well as discussions with Iron Mountain, another employer who implemented the Livongo for Diabetes program, we think the answer is a qualified ‘yes’ — as long as employers are willing to set clear objectives, carefully select a digital partner, be prepared for challenges and decide in advance what measures they will use to gauge success.”

>> Read NEBGH press release.